280 related articles for article (PubMed ID: 18162137)
1. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial.
Choudhury AB; Dawson CM; Kilvington HE; Eldridge S; James WY; Wedzicha JA; Feder GS; Griffiths CJ
Respir Res; 2007 Dec; 8(1):93. PubMed ID: 18162137
[TBL] [Abstract][Full Text] [Related]
2. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
3. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
[TBL] [Abstract][Full Text] [Related]
4. Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
Kunz LI; Ten Hacken NH; Lapperre TS; Timens W; Kerstjens HA; van Schadewijk A; Vonk JM; Sont JK; Snoeck-Stroband JB; Postma DS; Sterk PJ; Hiemstra PS;
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28049170
[TBL] [Abstract][Full Text] [Related]
5. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
[TBL] [Abstract][Full Text] [Related]
6. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J
Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
8. Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.
Cosío BG; Shafiek H; Iglesias A; Yanez A; Córdova R; Palou A; Rodriguez-Roisin R; Peces-Barba G; Pascual S; Gea J; Sibila O; Barnes PJ; Agusti A
Chest; 2016 Jul; 150(1):123-30. PubMed ID: 27107490
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
Cheng SL; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
[TBL] [Abstract][Full Text] [Related]
10. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
[TBL] [Abstract][Full Text] [Related]
11. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P
Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
[TBL] [Abstract][Full Text] [Related]
12. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.
Magnussen H; Watz H; Kirsten A; Decramer M; Dahl R; Calverley PM; Towse L; Finnigan H; Tetzlaff K; Disse B
Respir Med; 2014 Apr; 108(4):593-9. PubMed ID: 24477080
[TBL] [Abstract][Full Text] [Related]
13. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
14. COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care.
Thomas M; Radwan A; Stonham C; Marshall S
COPD; 2014 Jun; 11(3):300-9. PubMed ID: 24152210
[TBL] [Abstract][Full Text] [Related]
15. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.
Barnes NC; Sharma R; Lettis S; Calverley PM
Eur Respir J; 2016 May; 47(5):1374-82. PubMed ID: 26917606
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
17. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.
Calverley P; Pauwels R; Vestbo J; Jones P; Pride N; Gulsvik A; Anderson J; Maden C;
Lancet; 2003 Feb; 361(9356):449-56. PubMed ID: 12583942
[TBL] [Abstract][Full Text] [Related]
18. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
19. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
Mathioudakis AG; Bikov A; Foden P; Lahousse L; Brusselle G; Singh D; Vestbo J
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32108044
[TBL] [Abstract][Full Text] [Related]
20. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
